On June 9, 2025, Mallinckrodt plc announced the executive team for the combined company after merging with Endo, planning to spin off their generic pharmaceuticals businesses, which will be renamed 'Par Health' with Stephen Welch as CEO.
AI Assistant
MALLINCKRODT PLC
2025
8 K
Find Answers
Ask about any part of the document to get insights, explanations, or key details.